Drugs / Fecal Microbiota Transplantation Capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04729322 | Feb 2021 → Dec 2027 expected | colorectal adenocarcinoma, small intestine adenocarcinoma | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbiota Transplantation Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04729322 ↗ |
| Route | Oral | “Given PO” NCT04729322 ↗ |